Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin and Etoposide With or Without Epirubicin and Cyclophosphamide in Extensive Stage Small Cell Lung Cancer
NCT00003606Phase 3Completed
- Sponsor
- Unicancer
- Start
- Mar 1996
- Primary completion
- Oct 1999
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of epirubicin, cyclophosphamide in small cell lung cancer (SCLC), sponsored by Unicancer. Started Mar 1996; status: completed.
02
Drugs
epirubicincyclophosphamide
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00003606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003606.